W

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

IT Cybersecurity Co-op

Security Operations & Incident Response +1Confirmed live in the last 24 hours
Internship · Spring 2027Lexington, MA, USAIn-person

About the Job

Requirements

  • Enrollment in a bachelor's degree program in Computer Science or a related field at an accredited college or university.
  • A GPA of 3.0 or higher is preferred.
  • Strong background with the Windows operating system.
  • Strong written and verbal communication skills.
  • Ability to work in an organized manner and as part of a team.
  • Ability to manage responsibilities in a fast-paced environment.
  • Ability to take direction to resolve incidents quickly and effectively.
  • Ability to complete routine tasks independently over time, including developing the functional, technical, and problem-solving skills needed to complete assignments.

Responsibilities

  • Monitor alerts from CrowdStrike and other security platforms, investigate suspicious activity, and escalate incidents according to defined playbooks in support of the Security Operations Center.
  • Perform initial triage and enrichment of security events, document findings, and contribute to root-cause analyses.
  • Identify integration and ingestion points for security tools to improve telemetry and automation within the CrowdStrike platform and related systems.
  • Schedule, run, and review vulnerability scans across endpoints, servers, cloud environments, and network infrastructure.
  • Track remediation efforts with IT operations teams and ensure patches and fixes are applied in a timely manner.
  • Maintain reporting dashboards communicating remediation progress, trends, and compliance against defined service-level agreements.
  • Participate in projects advancing the organization's Zero Trust strategy, including implementing passwordless authentication methods and biometric access controls.
  • Review role-based access control configurations to ensure least-privilege principles are consistently applied.
  • Document and test identity governance initiatives, including access recertification and multi-factor authentication expansion.
  • Evaluate IT vendors and managed service providers by gathering documentation, reviewing security questionnaires, and scoring vendor cybersecurity posture.
  • Maintain third-party risk registers, coordinate remediation plans with vendor contacts, and track progress against action items.
  • Use tools such as BlackKite to expand third-party risk insights and reporting.
  • Contribute to cyber-AI risk assessments focused on the security and governance of open-source machine learning tools and large language model integrations.
  • Document risks related to data privacy, model security, and supply-chain vulnerabilities.
  • Support the development of mitigation strategies and track open AI-related risks.
  • Review, update, and publish cybersecurity policies and procedures to align with evolving best practices and regulatory requirements.
  • Manage the Written Information Security Program and related documentation.
  • Support mock assessments and evidence collection for frameworks such as ISO 27001 and the NIST Cybersecurity Framework in preparation for external audits.
  • Design, execute, and analyze phishing simulations and security awareness campaigns.
  • Deliver cybersecurity training sessions, gather feedback, and identify opportunities for improvement.
  • Develop shorter, focused training modules to increase employee engagement and knowledge retention.

Desired Qualifications

  • A GPA of 3.0 or higher.

About the Company

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

Wave Life Sciences develops stereopure nucleic acid therapies for genetically defined diseases. Its PRISM platform designs stereopure oligonucleotides that enable RNA interference, antisense silencing, splicing modulation, and RNA editing, including AIMers that recruit ADAR enzymes to edit RNA without changing the DNA. The company funds R&D mainly through partnerships and licensing (notably with GSK) and has programs in conditions like Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity. Its goal is to bring approved RNA medicines to patients by advancing a diversified pipeline and sustaining long-term collaborations that fund development.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Wave Life Sciences USA

See more jobs